CN100436417C - 一种光学活性氨氯地平的拆分方法 - Google Patents
一种光学活性氨氯地平的拆分方法 Download PDFInfo
- Publication number
- CN100436417C CN100436417C CNB2006100769353A CN200610076935A CN100436417C CN 100436417 C CN100436417 C CN 100436417C CN B2006100769353 A CNB2006100769353 A CN B2006100769353A CN 200610076935 A CN200610076935 A CN 200610076935A CN 100436417 C CN100436417 C CN 100436417C
- Authority
- CN
- China
- Prior art keywords
- amlodipine
- preparation
- basic
- sulfoxides
- basic sulfoxides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960000528 amlodipine Drugs 0.000 title claims abstract description 33
- HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 14
- HTIQEAQVCYTUBX-QGZVFWFLSA-N (R)-amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@H]1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-QGZVFWFLSA-N 0.000 claims abstract description 13
- 239000012046 mixed solvent Substances 0.000 claims abstract description 11
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims abstract description 6
- 150000003462 sulfoxides Chemical class 0.000 claims description 33
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 12
- 239000012453 solvate Substances 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- FEWJPZIEWOKRBE-LWMBPPNESA-L D-tartrate(2-) Chemical compound [O-]C(=O)[C@@H](O)[C@H](O)C([O-])=O FEWJPZIEWOKRBE-LWMBPPNESA-L 0.000 claims description 8
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 7
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Natural products CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 5
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 4
- 238000006386 neutralization reaction Methods 0.000 claims description 4
- 238000007670 refining Methods 0.000 claims description 4
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical group COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 3
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 18
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- VTRRCXRVEQTTOE-UHFFFAOYSA-N 1-methylsulfinylethane Chemical group CCS(C)=O VTRRCXRVEQTTOE-UHFFFAOYSA-N 0.000 abstract 2
- 229960001270 d- tartaric acid Drugs 0.000 abstract 1
- FEWJPZIEWOKRBE-LWMBPPNESA-N levotartaric acid Chemical group OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 230000006837 decompression Effects 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 3
- 150000003568 thioethers Chemical class 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 208000007718 Stable Angina Diseases 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 2
- 239000000292 calcium oxide Substances 0.000 description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 2
- 229960001701 chloroform Drugs 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Description
| 助溶剂 | 混合溶剂组成(V<sub>助溶 剂</sub>∶V<sub>总溶剂</sub>)% | (S)-(-)-氨氯地平ee% |
| 水 | 15 | 98.1 |
| 正丁醇 | 4 | 98.0 |
| 乙酸甲酯 | 3 | 96.3 |
| 三氯甲烷 | 2 | 97.6 |
| 2-丁酮 | 2 | 97.8 |
| DMSO | 30 | 98.8 |
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100769353A CN100436417C (zh) | 2006-04-11 | 2006-04-11 | 一种光学活性氨氯地平的拆分方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100769353A CN100436417C (zh) | 2006-04-11 | 2006-04-11 | 一种光学活性氨氯地平的拆分方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1927836A CN1927836A (zh) | 2007-03-14 |
| CN100436417C true CN100436417C (zh) | 2008-11-26 |
Family
ID=37857990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100769353A Active CN100436417C (zh) | 2006-04-11 | 2006-04-11 | 一种光学活性氨氯地平的拆分方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100436417C (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112079770B (zh) * | 2020-10-05 | 2024-01-02 | 湖南理工学院 | 用于高效手性拆分及母液原位再生的循环萃取和非对映体结晶耦合新方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1144523A (zh) * | 1994-03-24 | 1997-03-05 | 辉瑞研究与发展公司 | 由阿罗地平的非对映的酒石酸盐分离其对映体 |
| CN1267669A (zh) * | 2000-02-21 | 2000-09-27 | 张喜田 | 氨氯地平对映体的拆分 |
| CN1608051A (zh) * | 2001-10-24 | 2005-04-20 | 塞普拉科有限公司 | 拆分氨氯地平外消旋体的方法 |
| CN1609102A (zh) * | 2003-12-05 | 2005-04-27 | 石家庄制药集团欧意药业有限公司 | 一种光学活性氨氯地平的拆分方法 |
| CN1681786A (zh) * | 2002-09-11 | 2005-10-12 | 韩林制药株式会社 | S-(-)-氨氯地平的制备方法 |
-
2006
- 2006-04-11 CN CNB2006100769353A patent/CN100436417C/zh active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1144523A (zh) * | 1994-03-24 | 1997-03-05 | 辉瑞研究与发展公司 | 由阿罗地平的非对映的酒石酸盐分离其对映体 |
| US5750707A (en) * | 1994-03-24 | 1998-05-12 | Pfizer Inc. | Separation of the enantiomers of amlodipine via their diastereomeric tartrates |
| CN1267669A (zh) * | 2000-02-21 | 2000-09-27 | 张喜田 | 氨氯地平对映体的拆分 |
| CN1608051A (zh) * | 2001-10-24 | 2005-04-20 | 塞普拉科有限公司 | 拆分氨氯地平外消旋体的方法 |
| CN1681786A (zh) * | 2002-09-11 | 2005-10-12 | 韩林制药株式会社 | S-(-)-氨氯地平的制备方法 |
| CN1609102A (zh) * | 2003-12-05 | 2005-04-27 | 石家庄制药集团欧意药业有限公司 | 一种光学活性氨氯地平的拆分方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1927836A (zh) | 2007-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2483065C2 (ru) | Соли 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино) бензамида | |
| JP6285968B2 (ja) | (2s,5r)−6−ベンジルオキシ−7−オキソ−1,6−ジアザ−ビシクロ[3.2.1]オクタン−2−カルボン酸のナトリウム塩およびその調製 | |
| CN101798280B (zh) | 一种手性拆分消旋体氨氯地平制备s-(-)-氨氯地平和r-(+)-氨氯地平的方法 | |
| RU2337096C2 (ru) | Способ получения стереоизомера гликопиррония r,r (или s,s)-конфигурации | |
| CN101531629B (zh) | 由消旋的马来酸氨氯地平制备左旋氨氯地平的方法 | |
| CN100436417C (zh) | 一种光学活性氨氯地平的拆分方法 | |
| JP5585822B2 (ja) | 光学活性ニペコチン酸誘導体の製造方法 | |
| AU2022201401B2 (en) | Aldosterone synthase inhibitor | |
| US8362042B2 (en) | Stable R(+)-lansoprazole amine salt and a process for preparing the same | |
| JP5664870B2 (ja) | 3環性ベンゾピラン化合物の新規な結晶形態及びその製造方法 | |
| CN103922999B (zh) | 一种达比加群酯中间体的制备方法及中间体化合物 | |
| KR100515294B1 (ko) | 에스-(-)-암로디핀 니코티네이트 결정성 2수화물 | |
| CN1231469C (zh) | 一种光学活性氨氯地平的拆分方法 | |
| CN101544597B (zh) | S-(-)-氨氯地平的制备方法 | |
| JP5501054B2 (ja) | 3,3−ジアミノアクリル酸(1−ジフェニルメチルアゼチジン−3−イル)エステル酢酸塩の製造方法 | |
| KR101125123B1 (ko) | 높은 광학적 순도의 s-(-)-암로디핀을 제조하는 방법 및 그 중간생성 화합물 | |
| CN101654429B (zh) | 一种拆分获取s-(-)-氨氯地平的方法 | |
| KR101001646B1 (ko) | (r)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체 | |
| CN100532358C (zh) | 氨氯地平的拆分方法 | |
| KR100979772B1 (ko) | 광학적으로 순수한 에스-(-)-암로디핀 벤젠술폰산염의제조방법 | |
| WO2008053295A3 (en) | Pharmaceutical compositions of benzoquinolizine-2-carboxylic acid | |
| KR101085169B1 (ko) | 암로디핀 광학 이성질체의 분리방법 | |
| JP7498147B2 (ja) | アピキサバンの精製方法 | |
| JP2011057594A (ja) | ルイス酸を用いた4−(5−メチルピリジン−2−イルアミノ)ピペリジン−1−カルボン酸誘導体の製造方法 | |
| KR101724301B1 (ko) | 바레니클린 살리실산염의 i형 결정 및 그 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHIJIAZHUANG PHARMACEUTICAL GROUP OUYI PHARMA CO., Effective date: 20130509 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20130509 Address after: 050035 No. 226 the Yellow River Avenue, Shijiazhuang hi tech Development Zone, Hebei Patentee after: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. of CSPC Group Patentee after: Shijiazhuang Pharmaceutical Group Ouyi Pharma Co., Ltd. Address before: 050035 No. 226 the Yellow River Avenue, Shijiazhuang hi tech Development Zone, Hebei Patentee before: Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. of CSPC Group |